Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367
What this trial is testing

Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Second Affiliated Hospital, Zhejiang University, School of Medicine 135
Not applicableStudy completedNCT00096928
What this trial is testing

Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Who this might be right for
Psoriasis
Genentech, Inc. 1,846
Large-scale testing (Phase 3)Study completedNCT06122649
What this trial is testing

Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

Who this might be right for
Plaque Psoriasis
Amgen 203
Large-scale testing (Phase 3)Study completedNCT03410992
What this trial is testing

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 435
Testing effectiveness (Phase 2)Study completedNCT01043393
What this trial is testing

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT06844799
What this trial is testing

HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Hansoh BioMedical R&D Company 720
Large-scale testing (Phase 3)Ended earlyNCT00090129
What this trial is testing

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Arthritis, Psoriatic
EMD Serono 854
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07150988
What this trial is testing

A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 150
Post-approval studies (Phase 4)Looking for participantsNCT04347473
What this trial is testing

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 25
Testing effectiveness (Phase 2)Study completedNCT01225731
What this trial is testing

Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 355
Large-scale testing (Phase 3)Study completedNCT03535194
What this trial is testing

Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,484
Large-scale testing (Phase 3)Not Yet RecruitingNCT06943950
What this trial is testing

A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
CSPC Ouyi Pharmaceutical Co., Ltd. 500
Large-scale testing (Phase 3)Study completedNCT02581345
What this trial is testing

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPsoriasis
Momenta Pharmaceuticals, Inc. 572
Large-scale testing (Phase 3)Study completedNCT02902861
What this trial is testing

Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP)

Who this might be right for
Psoriasis Vulgaris
Prof. Kristian Reich 120
Testing effectiveness (Phase 2)UnknownNCT04785027
What this trial is testing

Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis

Who this might be right for
Traditional Chinese MedicineDrug EffectDrug Safety+2 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 16
Not applicableLooking for participantsNCT07532486
What this trial is testing

Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Testing effectiveness (Phase 2)Looking for participantsNCT07129382
What this trial is testing

Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Chipscreen Biosciences, Ltd. 220
Large-scale testing (Phase 3)Study completedNCT04167462
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea

Who this might be right for
Psoriasis
Bristol-Myers Squibb 220
Not applicableLooking for participantsNCT07234591
What this trial is testing

Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisModerate to Severe Plaque Psoriasis
Usynova Pharmaceuticals Ltd. 140
Large-scale testing (Phase 3)Study completedNCT05020249
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 47
Next Page